Minerva Biotechnologies is developing cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. Our stem cell technology could transform the field of regenerative medicine.
We discovered that cancer cells are healthy cells that are being reprogrammed back to a stem cell state. We can reverse the reprogramming and make cancer cells mature so that cancer growth is turned off. Th...
Minerva Biotechnologies is developing cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis. Our stem cell technology could transform the field of regenerative medicine.
We discovered that cancer cells are healthy cells that are being reprogrammed back to a stem cell state. We can reverse the reprogramming and make cancer cells mature so that cancer growth is turned off. This is a unique approach to curing cancer
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.